Your browser doesn't support javascript.
loading
Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study.
Sam, Susan; Edelstein, Sharon L; Arslanian, Silva A; Barengolts, Elena; Buchanan, Thomas A; Caprio, Sonia; Ehrmann, David A; Hannon, Tamara S; Tjaden, Ashley Hogan; Kahn, Steven E; Mather, Kieren J; Tripputi, Mark; Utzschneider, Kristina M; Xiang, Anny H; Nadeau, Kristen J.
Afiliação
  • Sam S; University of Chicago, Chicago, IL.
  • Edelstein SL; George Washington University Biostatistics Center, Washington, DC.
  • Arslanian SA; University of Pittsburgh Medical Center-Children's Hospital of Pittsburgh, Pittsburgh, PA.
  • Barengolts E; University of Chicago, Chicago, IL.
  • Buchanan TA; University of Southern California Keck School of Medicine, Los Angeles, CA.
  • Caprio S; Yale University, New Haven, CT.
  • Ehrmann DA; University of Chicago, Chicago, IL.
  • Hannon TS; Indiana University School of Medicine, Indianapolis, IN.
  • Tjaden AH; George Washington University Biostatistics Center, Washington, DC.
  • Kahn SE; Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, WA.
  • Mather KJ; Indiana University School of Medicine, Indianapolis, IN.
  • Tripputi M; George Washington University Biostatistics Center, Washington, DC.
  • Utzschneider KM; Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, WA.
  • Xiang AH; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
  • Nadeau KJ; University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO.
Diabetes Care ; 44(9): 1938-1947, 2021 09.
Article em En | MEDLINE | ID: mdl-34131048
ABSTRACT

OBJECTIVE:

To identify predictors of glycemic worsening among youth and adults with impaired glucose tolerance (IGT) or recently diagnosed type 2 diabetes in the Restoring Insulin Secretion (RISE) Study. RESEARCH DESIGN AND

METHODS:

A total of 91 youth (10-19 years) were randomized 11 to 12 months of metformin (MET) or 3 months of glargine, followed by 9 months of metformin (G-MET), and 267 adults were randomized to MET, G-MET, liraglutide plus MET (LIRA+MET), or placebo for 12 months. All participants underwent a baseline hyperglycemic clamp and a 3-h oral glucose tolerance test (OGTT) at baseline, month 6, month 12, and off treatment at month 15 and month 21. Cox models identified baseline predictors of glycemic worsening (HbA1c increase ≥0.5% from baseline).

RESULTS:

Glycemic worsening occurred in 17.8% of youth versus 7.5% of adults at month 12 (P = 0.008) and in 36% of youth versus 20% of adults at month 21 (P = 0.002). In youth, glycemic worsening did not differ by treatment. In adults, month 12 glycemic worsening was less on LIRA+MET versus placebo (hazard ratio 0.21, 95% CI 0.05-0.96, P = 0.044). In both age-groups, lower baseline clamp-derived ß-cell responses predicted month 12 and month 21 glycemic worsening (P < 0.01). Lower baseline OGTT-derived ß-cell responses predicted month 21 worsening (P < 0.05). In youth, higher baseline HbA1c and 2-h glucose predicted month 12 and month 21 glycemic worsening, and higher fasting glucose predicted month 21 worsening (P < 0.05). In adults, lower clamp- and OGTT-derived insulin sensitivity predicted month 12 and month 21 worsening (P < 0.05).

CONCLUSIONS:

Glycemic worsening was more common among youth than adults with IGT or recently diagnosed type 2 diabetes, predicted by lower baseline ß-cell responses in both groups, hyperglycemia in youth, and insulin resistance in adults.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Intolerância à Glucose / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Intolerância à Glucose / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel